Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/7312
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Coleções
Metadata
Mostrar registro completo
ANTIMALARIAL DRUG DISCOVERY: SCREENING OF BRAZILIAN MEDICINAL PLANTS AND PURIFIED COMPOUND
artemisinin derivatives
chloroquine resistance
drug discovery
drug resistance
malaria, medicinal plants
Phmodium falcipamm
quinìne
Krettli, Antoniana Ursine | Data do documento:
2009
Autor(es)
Afiliação
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Malária. Belo Horizonte,MG, Brazil
Resumo em Inglês
Background: Malaria is the most important parasitic disease and its control depends on specific chemotherapy, now complicated by Plasmodium falciparum that has become resistant to most commonly available antimalarials. Treatment of the disease requires quinine or drug combinations of artemisinin derivatives and other antimalarials. Further drug resistance is expected. New active compounds need to be discovered.
Objective/method: To find new anti-malarials from medicinal and randomly collected plants, crude extracts are screened against P. falciparum in cultures and in malaria animal moders, following bioassays of purified fractions, and cytotoxicity tests.
Conclusion: For antimalarial research, screening medicinal plants is more efficient than screening randomly chosen plants. Biomonitored fractionation allows selection of new active molecules identified as potential antimalarials in multidisciplinary projects in Brazil; no new molecule is available for human testing. The advantages of projects based on ethnopharmacology are discussed.
Palavras-chave em inglês
antimalarialsartemisinin derivatives
chloroquine resistance
drug discovery
drug resistance
malaria, medicinal plants
Phmodium falcipamm
quinìne
Compartilhar